BioSpace News Archive

Business

Aclaris Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides R&D and Business Highlights

Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a physician-led biopharmaceutical company focused on immuno-inflammatory diseases, today announced its financial results for the fourth quarter and full year 2019 and provided research and development (R&D) and business highlights.

February 25, 2020

·

10 min read

Business

Paratek Pharmaceuticals Announces Full Year 2019 Total Revenues of $16.5 Million including NUZYRA® (omadacycline) Net Sales of $11.5 Million

Paratek Expects Full Year 2020 Total Revenues to be Between $75 and $80 Million including NUZYRA Net Sales of Approximately $66 Million

February 25, 2020

·

13 min read

Business

Allakos Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update

Allakos Inc. reported financial results for the fourth quarter and full year ended December 31, 2019 and provided an update of its ongoing and planned development activities.

February 25, 2020

·

7 min read

Business

GW Pharmaceuticals plc Reports Fourth Quarter and Year-End 2019 Financial Results and Operational Progress

GW Pharmaceuticals plc, a world leader in the science, development, and commercialization of cannabinoid prescription medicines, announces financial results for the fourth quarter and full-year ended December 31, 2019.

February 25, 2020

·

10 min read

Deals

RTI Surgical Holdings, Inc.® Announces Postponement of Record Date and Stockholder Meeting Date for Sale of OEM Business

RTI Surgical Holdings, Inc. announced that it has postponed the special meeting of its shareholders, which was scheduled for March 31, 2020 to, among other things, consider and vote on various proposals necessary to close the previously announced Equity Purchase Agreement, dated January 13, 2020

February 25, 2020

·

5 min read

Biotech Bay

Sunesis Pharmaceuticals to Present at the 40th Annual Cowen Health Care Conference

Sunesis Pharmaceuticals, Inc. announced that Willie Quinn, Chief Financial Officer and Senior Vice President, Finance and Corporate Development of Sunesis, will present at the 40th Annual Cowen Health Care Conference on Tuesday, March 3, 2020 at 10:00 AM Eastern Standard Time in Boston, Massachusetts.

February 25, 2020

·

1 min read

Biotech Beach

Neurocrine Biosciences to Present at Cowen 40th Annual Health Care Conference

Neurocrine Biosciences, Inc. will present at the Cowen 40th Annual Health Care Conference at 12:00 p.m. Eastern Time on Tuesday, Mar. 3, 2020, in Boston.

February 25, 2020

·

1 min read

Business

Adamas Reports Fourth Quarter and Full Year 2019 Financial Results

Full year 2019 GOCOVRI® product sales of $54.6 million, a 60% increase over 2018; total paid prescriptions grew approximately 66% to 25,780

February 25, 2020

·

8 min read

Drug Development

Novavax’ Preclinical NanoFlu Data Published in Vaccines; Details Structural Basis for Broadly Neutralizing Immunity

Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced a publication in Vaccines describing the immunogenic potential of NanoFlu™, Novavax’ recombinant seasonal influenza vaccine candidate adjuvanted with Matrix-M™.

February 25, 2020

·

3 min read

Biotech Beach

Heron Therapeutics to Present at the 40th Annual Cowen Healthcare Conference

Heron Therapeutics, Inc. announced that Barry Quart, Pharm.D., President and Chief Executive Officer of Heron Therapeutics, will present at the 40th Annual Cowen Healthcare Conference on Monday, March 2nd, 2020 at 12:00 p.m. ET at the Boston Marriott Copley Place hotel.

February 25, 2020

·

1 min read